Navigation Links
Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis
Date:7/7/2009

/a> a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine, a new generation nucleoside analog which has demonstrated both pre-clinical and clinical activity in certain cancers. For additional information on Access Pharmaceuticals, please visit our website at www.accesspharma.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, and that involve risks and uncertainties. These statements include those relating to: clinical trial plans and timelines and clinical results for ProLindac and product candidates acquired in the MacroChem transaction, our ability to execute licensing agreements in the future, Access' plans to continue and initiate clinical trials, the value of its products in the market (including MuGard and the size of the overall market for mucositis products), its ability to achieve clinical and commercial success and its ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited Access' need to obtain additional financing in order to continue the clinical trial and operations and to the risks detailed in Access' Annual Reports on Form 10-K and other reports filed by Access with the Securities and Exchange Commission.

    Contact: Company                Contact: Investor Relations
    Stephen B. Thompson             Donald C. Weinberger/Diana Bittner (media)
    Vice President                  Wolfe Axelrod Weinberger Assoc. LLC
    Chief Financial Officer        (212) 370-4500
    Access Pharmaceuticals, Inc.
    (214) 905-5100


'/>"/>
SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
2. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
3. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
4. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
5. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
6. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
7. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
8. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
9. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
10. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
11. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 5, 2015   Temptime Corporation ... the health care industry, announced today that its board ... Hooff to chief executive officer.  Mr. Van ... Temptime since 2011. "Renaat deeply values Temptime,s ... outstanding job of expanding Temptime,s products and services to ...
(Date:5/5/2015)... 2015  Trovagene, Inc. (NASDAQ:  TROV), a developer ... results for the three months ended March 31, ... we presented favorable clinical results at ASCO GI, ... our Precision Cancer Monitoring platform,s ability to detect ... lung cancers," said Antonius Schuh, Ph.D., chief executive ...
(Date:5/5/2015)... /CNW Telbec/ - Ergoresearch Ltd (TSXV: ERG) ... known under the « Équilibre, orthèses et biomécanique» ... previously announced on April 23, 2015 regarding the acquisition ... Orthoconcept (2008) inc.   The purchase price ... ERG) to the vending shareholder, namely 9211-5096 Québec inc.. ...
Breaking Medicine Technology:Temptime President Renaat Van den Hooff Promoted to CEO 2Trovagene, Inc. Announces First Quarter 2015 Financial Results 2Trovagene, Inc. Announces First Quarter 2015 Financial Results 3Trovagene, Inc. Announces First Quarter 2015 Financial Results 4Trovagene, Inc. Announces First Quarter 2015 Financial Results 5Trovagene, Inc. Announces First Quarter 2015 Financial Results 6Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 2Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 3
(Date:5/6/2015)... 2015 When it comes to advice ... reputable and respected than those of a physician. It ... physician lose more weight than those who received no ... by the University of Georgia and published in the ... that patients advised by their physicians dropped more pounds, ...
(Date:5/6/2015)... Launch Corporation, LLC. is pleased to announce that ... at 17 Tanguay Avenue. Owned and operated by Rick Arnold ... location in New England. , “We are extremely excited for ... founder, co-owner and CEO of Launch. “They have established great ... seeing them continue to establish that positive growth in the ...
(Date:5/6/2015)... NC (PRWEB) May 06, 2015 LINET ... Award of Charlotte in the small business category. The ... The Mayor’s International Community Award is given on an ... area that exhibit outstanding contributions to philanthropy. Since ... the Mayor have hosted the Mayor’s International Community Awards. ...
(Date:5/6/2015)... “ Radiation Island ” was featured on ... look at the latest and coolest applications on the market ... AppWatch and technology expert, conducted the app review and shared ... games on iOS. , Touted as one of the best ... by users, which is obvious because of its rating of ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 With ProPoint: Hand ... within Final Cut Pro X . With ProPoint: ... 3D space to further more customize each preset all with ... are given up to 90 fully customizable effect presets all ... circles, curved arrows, straight arrows, underlines, and more. , ...
Breaking Medicine News(10 mins):Health News:Diet Doc Unveils New Protocol Around Doctor Advised Weight Loss 2Health News:Diet Doc Unveils New Protocol Around Doctor Advised Weight Loss 3Health News:Jump Up and Celebrate: Launch Trampoline Park Opens in Nashua, NH 2Health News:LINET Americas Wins The Mayor's International Community Award in Charlotte 2Health News:Top Grossing iPhone Game, Radiation Island, Was Featured on NewsWatch 2Health News:FCPX Plugin Developer Pixel Film Studios release Propoint Hand Drawn 2
... the Long-Term Care market -LISLE, IL, Jan. 5 ... the "Company") (NASDAQ: SXCI , TSX: ... benefit management services, announces that its Health Care ... three-year, multi-million dollar contract to provide its Resident ...
... GUANGZHOU, China, Jan. 5 /PRNewswire-Asia/ -- China Medicine ... Company"), a leading,developer and distributor of prescription and ... and dietary supplements,medical devices and medical formulations, announced ... Investor Relations for a primary term of one ...
... 2008, Laura Plummer made enough New,Year,s resolutions for six ... exercising, ate healthfully, lost 35 pounds, lowered her cholesterol,and ... according to RealAge.com,s,patented test. , ... Winfrey Show" came,calling. On Tuesday, January 6, Plummer will ...
... Lumenis announces 510(k) approval for the new AcuPulse ... Jan. 5 Lumenis Inc., a global ... radiofrequency devices for surgical, aesthetic, and ophthalmic applications, ... of its new AcuPulse CO2 Laser for ENT, ...
... Lark is proud to announce that she is reformulating her squalane skin ... than sharks. , ... Potomac, MD (PRWEB) January 5, 2009 -- Dr. ... skin care line. The new line will contain squalane sourced from olives ...
... services company, outlines the next steps following SSDI denial , ... ... denial letter from the Social Security Administration can be devastating, but ... to Allsup , which represents tens of thousands of people ...
Cached Medicine News:Health News:SXC Health Solutions announces contract with PharMerica 2Health News:China Medicine Renews Contract with CCG Investor Relations 2Health News:China Medicine Renews Contract with CCG Investor Relations 3Health News:Taking 20 Years Off Her Health and Looks, RealAge Member Flaunts It on 'Oprah' Show 2Health News:An Evolution in Automated CO2 Laser Surgery 2Health News:Dr. Susan Lark's Squalane Now Made From Olives, Not Sharks 2Health News:Dr. Susan Lark's Squalane Now Made From Olives, Not Sharks 3Health News:You've Just Been Denied Social Security Disability--Now What? 2Health News:You've Just Been Denied Social Security Disability--Now What? 3Health News:You've Just Been Denied Social Security Disability--Now What? 4
... This model offers all of the ... 2 densitometer with the additional feature ... a small imaging scanner for importing ... immunofixation results or images. This additional ...
Inquire...
... Sebia's Normal and Hypergamma Controls ... on either agarose gels or ... system. Our unique control manufacturing ... as the other serum components, ...
... gel electrophoresis system is designed to ... in classic electrophoresis and immunofixation testing. ... phases of electrophoresis from sample ... staining, destaining and drying. The walkaway ...
Medicine Products: